Acceptability and efficacy of partner notification for curable sexually transmitted infections in sub-Saharan Africa: A systematic review.
Africa
Chlamydia ()
Gonorrhea ()
bacterial disease
protozoal disease
trichomoniasis ()
Journal
International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
7
11
2018
medline:
10
9
2019
entrez:
7
11
2018
Statut:
ppublish
Résumé
Comprehensive case management of sexually transmitted infections (STIs) includes partner notification. We reviewed the recent literature evaluating the acceptability and efficacy of partner notification strategies (i.e. direct patient referral, provider referral, or expedited partner treatment) for curable STIs in sub-Saharan Africa. We conducted a systematic search following PRISMA guidelines: published January 2008 to June 2017 in the English language, study in sub-Saharan Africa, and discussion of any curable STI with an outcome on partner notification. We searched six electronic databases, conference abstracts, online clinical trial registries, and article bibliographies. The results showed that out of the 74 identified articles, 55 did not meet inclusion criteria. Of the 11 studies evaluating direct patient referral, the proportion of index cases ( n = 4163) who successfully notified sex partner(s) was 53% (range 23-95%). Among those who notified ( n = 1727), 25% (range 0-77%) had partner(s) that sought evaluation (95% CI 0.51-0.54; 95% CI 0.23-0.27). Both provider referral and expedited partner treatment had higher proportions of partner(s) who sought treatment ( n = 208, 69% and n = 44, 84%, respectively). Direct patient referral is the most commonly used and evaluated partner notification strategy for STIs in sub-Saharan Africa with mixed success. We recommend future research to investigate other strategies such as expedited partner treatment.
Identifiants
pubmed: 30396318
doi: 10.1177/0956462418803983
pmc: PMC6441466
mid: NIHMS1012580
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
292-303Subventions
Organisme : FIC NIH HHS
ID : D43 TW009343
Pays : United States
Organisme : FIC NIH HHS
ID : K01 TW011187
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH080634
Pays : United States
Références
Sex Transm Dis. 2016 Jan;43(1):23-9
pubmed: 26650992
Lancet. 2004 Oct 30-Nov 5;364(9445):1561-3
pubmed: 15519615
Cochrane Database Syst Rev. 2013 Oct 03;(10):CD002843
pubmed: 24092529
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
BMC Infect Dis. 2015 Jan 13;15:15
pubmed: 25583097
Sex Transm Dis. 2015 Nov;42(11):637-42
pubmed: 26462189
BMJ Clin Evid. 2009 May 20;2009:
pubmed: 21733200
Int J STD AIDS. 2014 Oct;25(12):851-9
pubmed: 24516075
Confl Health. 2008 Oct 23;2:14
pubmed: 18947393
Trop Med Int Health. 2010 Sep;15(9):1090-8
pubmed: 20636304
Int J STD AIDS. 2012 May;23(5):325-9
pubmed: 22648885
Glob J Health Sci. 2012 Aug 13;4(5):156-71
pubmed: 22980389
S Afr Med J. 2013 Oct 11;104(1):42-4
pubmed: 24388087
PLoS One. 2016 May 12;11(5):e0155383
pubmed: 27171270
BMC Public Health. 2010 Jan 18;10:19
pubmed: 20082718
Int J STD AIDS. 2017 Oct;28(12):1184-1189
pubmed: 28166698
Sex Transm Infect. 2017 Jun;93(4):247-252
pubmed: 28130505
Sex Transm Infect. 2016 Mar;92(2):135-41
pubmed: 26430128
PLoS One. 2015 Dec 08;10(12):e0143304
pubmed: 26646541
Int J STD AIDS. 2013 Feb;24(2):139-43
pubmed: 23514831
J Public Health (Oxf). 2017 Jun 1;39(2):407-414
pubmed: 27222237